| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurosurgery (Drs. Antinheimo and Jääskeläinen), Neurology (Dr. Sainio), and Pathology (Dr. Carpén), University of Helsinki; and The Finnish Cancer Registry (Drs. Sankila and Pukkala), Helsinki, Finland.
Address correspondence and reprint requests to Dr. Jussi Antinheimo, Department of Neurosurgery, Helsinki University Hospital, Topeliuksenkatu 5, FIN-00260 Helsinki, Finland; e-mail: jussi.antinheimo{at}helsinki.fi
OBJECTIVE: To estimate the incidence of meningiomatosis and schwannomatosis, and their familial occurrences and relation to type 2 neurofibromatosis (NF2) in a well-defined population.
METHODS: Patients with histologically verified intracranial, spinal, or peripheral schwannomas or meningiomas, who were residents of the Helsinki University Hospital catchment area (population, 1,713,000) from January 1, 1985, to December 31, 1995, were included in the study. The Population Register Center was used to identify relatives of all the patients, and their data were linked further to the Finnish Cancer Registry to find NF2-related tumors. Detailed pedigrees were constructed for the patients with NF2, schwannomatosis, meningiomatosis, patients with relatives with histologically verified schwannomas or meningiomas, and patients younger than 25 years of age at the time of diagnosis.
RESULTS: Approximately 3% (12 of 455) of the schwannoma patients had multiple schwannomas in association with NF2, and 2% (11 of 455) had schwannomatosis without NF2. Two of the patients with schwannomatosis (2 of 11) had familial schwannomatosis. Approximately 1% (7 of 823) of the patients with meningioma had multiple meningiomas in association with NF2, and 4% (29 of 823) had meningiomatosis without NF2. No families with meningiomatosis were found among the 823 patients with meningioma studied. The birth occurrence of NF2 was 1 in 87,410.
CONCLUSIONS: The current diagnostic criteria of type 2 neurofibromatosis (NF2) seem valid because NF2 patients were differentiated rather easily from patients with sporadic schwannomatosis and meningiomatosis. Familial meningiomatosis, if it truly exists, is very rare, and familial schwannomatosis is uncommon.
Key words: Neurofibromatosis 2—Meningioma—Schwannoma—Schwannomatosis—Meningiomatosis—Incidence—Epidemiology
This article has been cited by other articles:
|
|
 |
|
  C. O. Hanemann Magic but treatable? Tumours due to loss of Merlin Brain, March 1, 2008; 131(3): 606 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Malmer, P. Adatto, G. Armstrong, J. Barnholtz-Sloan, J. L. Bernstein, E. Claus, F. Davis, R. Houlston, D. Il'yasova, R. Jenkins, et al. GLIOGENE an International Consortium to Understand Familial Glioma Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1730 - 1734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Begnami, E. J. Rushing, M. Santi, and M. Quezado Evaluation of NF2 Gene Deletion in Pediatric Meningiomas Using Chromogenic In Situ Hybridization International Journal of Surgical Pathology, April 1, 2007; 15(2): 110 - 115. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Sathornsumetee, A. DesJardins, D. A. Reardon, J. N. Rich, and J. J. Vredenburgh Neurofibromatosis type 2 Neurology, March 27, 2007; 68(13): E14 - E14. [Full Text] [PDF]
|
|
|
|
 |
|
 Image of the Month--Diagnosis Arch Surg, September 1, 2006; 141(9): 942 - 942. [Full Text] [PDF]
|
|
|
|
 |
|
 M E Baser and T Y Poussaint Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma J. Med. Genet., March 1, 2006; 43(3): 285 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. MacCollin, E. A. Chiocca, D. G. Evans, J. M. Friedman, R. Horvitz, D. Jaramillo, M. Lev, V. F. Mautner, M. Niimura, S. R. Plotkin, et al. Diagnostic criteria for schwannomatosis Neurology, June 14, 2005; 64(11): 1838 - 1845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D G R Evans, C Watson, A King, A J Wallace, and M E Baser Multiple meningiomas: differential involvement of the NF2 gene in children and adults J. Med. Genet., January 1, 2005; 42(1): 45 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Ruggieri, P Pavone, A Polizzi, M D. Pietro, A Scuderi, A Gabriele, A Spalice, and P Iannetti Ophthalmological manifestations in segmental neurofibromatosis type 1 Br J Ophthalmol, November 1, 2004; 88(11): 1429 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Lesley, M. R. Thomas, and S. I. Abdulrauf N-Butylcyanoacrylate Embolization of a Middle Meningeal Artery Aneurysm in a Patient with Neurofibromatosis Type 2 AJNR Am. J. Neuroradiol., September 1, 2004; 25(8): 1414 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Kaufman, B. S. Heinrich, C. Willett, A. Perry, F. Finseth, R. A. Sobel, and M. MacCollin Somatic Instability of the NF2 Gene in Schwannomatosis Arch Neurol, September 1, 2003; 60(9): 1317 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. MacCollin, C. Willett, B. Heinrich, L. B. Jacoby, J. S. Acierno Jr., A. Perry, and D. N. Louis Familial schwannomatosis: Exclusion of the NF2 locus as the germline event Neurology, June 24, 2003; 60(12): 1968 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Chen, R. N. Samy, and B. J. Gantz Cerebellopontine Angle Tumor Composed of Schwann and Meningeal Proliferations Arch Otolaryngol Head Neck Surg, November 1, 2001; 127(11): 1385 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ruggieri and S. M. Huson The clinical and diagnostic implications mosaicism in the neurofibromatoses Neurology, June 12, 2001; 56(11): 1433 - 1443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. DeAngelis Brain Tumors N. Engl. J. Med., January 11, 2001; 344(2): 114 - 123. [Full Text] [PDF]
|
|
|
|
|
|
A. King and D. H. Gutmann The question of familial meningiomas and schwannomas:: NF2B or not to be? Neurology, January 11, 2000; 54(1): 4 - 4. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
